Related Experiment Video
Updated: Jan 18, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Membranes as targets and modifiers of mutant huntingtin aggregation
1Department of Biochemistry and Molecular Biology, University of Nevada, Reno, NV, USA.
Insights
Huntington's disease involves mutant huntingtin protein aggregation on cellular membranes. Understanding these interactions may reveal new therapeutic targets for this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Huntington's disease (HD) is a neurodegenerative disorder.
- It is caused by an expanded CAG repeat in the huntingtin (HTT) gene.
- This leads to an expanded polyglutamine (polyQ) tract in the HTT protein, forming mutant HTT (mHTT) that aggregates.
Purpose of the Study:
- To review membrane abnormalities in various HD models.
- To explore the interplay between mHTT binding to membranes and subsequent aggregation.
- To emphasize the role of N-terminal mHTT fragments in these interactions.
Main Methods:
- Review of existing literature on Huntington's disease models.
- Analysis of studies focusing on mHTT-membrane interactions.
- Examination of mHTT aggregation dynamics on cellular membranes.
Main Results:
- Membrane abnormalities are observed across different HD models.
- Cellular membranes influence mHTT aggregation in complex ways.
- mHTT interacts with and accumulates on cellular membranes, particularly N-terminal fragments.
Conclusions:
- Membrane interactions are a significant factor in HD pathogenesis.
- Understanding mHTT-lipid interactions could offer novel therapeutic strategies.
- Targeting these membrane interactions may complement existing therapeutic approaches for HD.
Abstract:
Huntington's disease (HD) is a neurodegenerative disorder caused by an expanded CAG repeat in the huntingtin (HTT) gene, resulting in an expanded polyglutamine (polyQ) tract in HTT protein. Expanded polyQ tracts cause mutant HTT (mHTT) to aggregate and accumulate as cellular inclusions. Recent studies highlight the interactions between mHTT and different cellular membranes that contribute to HD pathogenesis. Beyond being targets for mHTT-induced damage, membranes modify mHTT aggregation in a complex manner. This review explores the membrane abnormalities observed in a variety of HD models and the interplay between binding to and subsequent aggregation of mHTT on membranes, with an emphasis on N-terminal mHTT fragments. Understanding mHTT-lipid interactions may provide potential targets for therapeutic intervention that would complement other efforts.
More Related Videos
11:22Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Published on: June 27, 2018
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
SNAREs and Membrane Fusion
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...